Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 944 | 986 | 1027 | 1451 | 1492 | 2204 |
Fund Return | -5.62% | -1.43% | 2.72% | 13.22% | 8.33% | 8.22% |
Place in category | 1010 | 4988 | 571 | 287 | - | - |
% in Category | 15 | 76 | 9 | 7 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nykredit Invest Taktisk Allokering | 9.95B | 2.99 | 1.44 | 5.60 | ||
Nykredit Invest Globale Fokusak Akk | 6.61B | 12.19 | 10.11 | 11.91 | ||
Nykredit Invest Baredygtige Aktier | 4.5B | 8.06 | 10.00 | 11.50 | ||
Nykredit Invest Globale Aktier Basi | 4.29B | 8.03 | 13.08 | 11.63 | ||
Nykredit Invest Globale Fokusaktier | 3.46B | 9.24 | 10.79 | 12.21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danica Balance 100 Offensiv | 35.24B | 9.60 | 6.67 | 8.72 | ||
Nordea Invest Portefolje Aktier | 28.09B | 9.20 | 8.86 | 10.22 | ||
Danske Invest Engros Flexinv Aktier | 14.55B | 11.50 | 8.63 | 9.39 | ||
Nordea Invest Global Stars | 3.47B | 5.94 | 7.52 | 11.04 | ||
Formuepleje LimiTTellus | 10.96B | 8.49 | 6.09 | 9.83 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.37 | 397.84 | +0.73% | |
Alphabet A | US02079K3059 | 4.11 | 166.62 | +1.68% | |
Apple | US0378331005 | 3.65 | 173.18 | +2.29% | |
AbbVie | US00287Y1091 | 2.45 | 160.81 | -0.56% | |
Bristol-Myers Squibb | US1101221083 | 2.35 | 43.70 | -1.15% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review